Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex.
The factors responsible for ALS-parkinsonism dementia complex (ALS-PDC), the unique neurological disorder of Guam, remain unresolved, but identification of causal factors could lead to clues for related neurodegenerative disorders elsewhere. Earlier studies focused on the consumption and toxicity of the seed of Cycas circinalis, a traditional staple of the indigenous diet, but found no convincing evidence for toxin-linked neurodegeneration. We have reassessed the issue in a series of in vitro bioassays designed to isolate non-water soluble compounds from washed cycad flour and have identified three sterol beta-d-glucosides as potential neurotoxins. These compounds give depolarizing field potentials in cortical slices, induce alterations in the activity of specific protein kinases, and cause release of glutamate. They are also highly toxic, leading to release of lactate dehydrogenase (LDH). Theaglycone form, however, is non-toxic. NMDA receptor antagonists block the actions of the sterol glucosides, but do not compete for binding to the NMDA receptor. The most probable mechanism leading to cell death may involve glutamate neuro/excitotoxicity. Mice fed cycad seed flour containing the isolated sterol glucosides show behavioral and neuropathological outcomes, including increased TdT-mediated biotin-dUTP nick-end labelling (TUNEL) positivity in various CNS regions. Astrocytes in culture showed increased caspase-3 labeling after exposure to sterol glucosides. The present results support the hypothesis that cycad consumption may be an important factor in the etiology of ALS-PDC and further suggest that some sterol glucosides may be involved in other neurodegenerative disorders.
Khabazian
I
I
Department of Ophthalmology, University of British Columbia, Vancouver, Canada.
Bains
J S
JS
Williams
D E
DE
Cheung
J
J
Wilson
J M B
JM
Pasqualotto
B A
BA
Pelech
S L
SL
Andersen
R J
RJ
Wang
Y-T
YT
Liu
L
L
Nagai
A
A
Kim
S U
SU
Craig
U-K
UK
Shaw
C A
CA
D000690:Amyotrophic Lateral Sclerosis / Q000150:complications / Q000209:etiology*; D000818:Animals; D001253:Astrocytes / Q000166:cytology / Q000187:drug effects; D001681:Biological Assay; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D002784:Cholesterol / Q000031:analogs & derivatives* / Q000737:chemistry; D029784:Cycas; D003704:Dementia / Q000150:complications / Q000209:etiology; D005947:Glucose / Q000031:analogs & derivatives / Q000737:chemistry; D005960:Glucosides / Q000302:isolation & purification / Q000633:toxicity; D006141:Guam; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009474:Neurons / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D009498:Neurotoxins / Q000302:isolation & purification / Q000633:toxicity; D020734:Parkinsonian Disorders / Q000150:complications / Q000209:etiology; D018408:Patch-Clamp Techniques; D010840:Phytosterols / Q000737:chemistry / Q000302:isolation & purification* / Q000633:toxicity*; D010936:Plant Extracts / Q000737:chemistry / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects / Q000378:metabolism; D012639:Seeds / Q000737:chemistry*; D012855:Sitosterols / Q000302:isolation & purification / Q000633:toxicity; D013265:Stigmasterol / Q000031:analogs & derivatives / Q000737:chemistry / Q000302:isolation & purification / Q000633:toxicity
D005960:Glucosides; D009498:Neurotoxins; D010840:Phytosterols; D010936:Plant Extracts; D016194:Receptors, N-Methyl-D-Aspartate; D012855:Sitosterols; C422003:dihydrobrasicasterol; C464587:stigmasterol glucoside; C021273:campesterol; D002784:Cholesterol; D013265:Stigmasterol; D005947:Glucose; C011015:lyoniside